Cardiac Transcriptome Remodeling And Impaired Bioenergetics in Single-Ventricle Congenital Heart Disease
Overview
Authors
Affiliations
The mechanisms responsible for heart failure in single-ventricle congenital heart disease are unknown. Using explanted heart tissue, we showed that failing single-ventricle hearts have dysregulated metabolic pathways, impaired mitochondrial function, decreased activity of carnitine palmitoyltransferase activity, and altered functioning of the tricarboxylic acid cycle. Interestingly, nonfailing single-ventricle hearts demonstrated an intermediate metabolic phenotype suggesting that they are vulnerable to development of heart failure in the future. Mitochondrial targeted therapies and treatments aimed at normalizing energy generation could represent a novel approach to the treatment or prevention of heart failure in this vulnerable group of patients.
Mitochondrial Dysfunction in Congenital Heart Disease.
Pires Da Silva J, Casa de Vito M, Miyano C, Sucharov C J Cardiovasc Dev Dis. 2025; 12(2).
PMID: 39997476 PMC: 11856204. DOI: 10.3390/jcdd12020042.
Michel M, Renaud D, Schmidt R, Einkemmer M, Laser L, Michel E Int J Mol Sci. 2024; 25(10).
PMID: 38791454 PMC: 11121818. DOI: 10.3390/ijms25105416.
Renaud D, Scholl-Burgi S, Karall D, Michel M Metabolites. 2023; 13(8).
PMID: 37623876 PMC: 10456471. DOI: 10.3390/metabo13080932.
Lopaschuk G, Persad K JACC Basic Transl Sci. 2023; 8(3):280-282.
PMID: 37034282 PMC: 10077119. DOI: 10.1016/j.jacbts.2023.01.017.